Health DG: Will take four months to evaluate Pfizer trial data

  • Nation
  • Monday, 21 Dec 2020

PUTRAJAYA: It will take up to four months for the National Pharmaceutical Regulatory Agency (NPRA) to evaluate the clinical trial data provided by pharmaceutical giant Pfizer on the Covid-19 vaccine it has developed.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the NPRA received a formal application from Pfizer on Dec 15 to have its Covid-19 vaccine registered in Malaysia.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Nation

Six men, one woman held for threatening and beating man in Kota Kinabalu
Coalition Duchenne back for 11th charity climb, funds RM20,000 for rare disease
Mitra to implement socio-economic development programme with RM7.2mil allocation
Teen hiker rescued after fall at Sepanggar hill
Two killed, two in critical condition in 4WD crash
Potential cooperation between Muhyiddin and Dr M marks a turning point, says FT Perikatan info chief
PM Anwar hopes conglomerates will support development of the arts
Mohd Ali appointed Kelantan deputy police chief
MBPP seeks damages from company over Weld Quay pedestrian bridge damage
Tok Mat attends Shangri-La dialogue in Singapore

Others Also Read